EQUITY RESIDENTIAL — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EQUITY RESIDENTIAL filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $2.70B | Feb 20, 2020 |
| FY2019 | Dec 31, 2018 | $2.58B | Feb 20, 2020 |
| FY2019 | Dec 31, 2017 | $2.47B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $2.43B | Feb 21, 2019 |
| FY2017 | Dec 31, 2015 | $2.74B | Feb 22, 2018 |
| FY2016 | Dec 31, 2014 | $2.61B | Feb 23, 2017 |
| FY2015 | Dec 31, 2013 | $2.39B | Feb 25, 2016 |
| FY2014 | Dec 31, 2012 | $1.75B | Feb 26, 2015 |
| FY2013 | Dec 31, 2011 | $1.53B | Feb 27, 2014 |
| FY2012 | Dec 31, 2010 | $1.67B | Feb 21, 2013 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Sep 30, 2013 | $626.63M | Feb 27, 2014 |
| FY2013 | Jun 30, 2013 | $617.22M | Feb 27, 2014 |
| FY2013 | Mar 31, 2013 | $504.72M | Feb 27, 2014 |
| FY2013 | Dec 31, 2012 | $452.48M | Feb 27, 2014 |
| FY2012 | Sep 30, 2012 | $544.67M | Feb 21, 2013 |
| FY2012 | Jun 30, 2012 | $525.63M | Feb 21, 2013 |
| FY2012 | Mar 31, 2012 | $505.76M | Feb 21, 2013 |
| FY2011 | Dec 31, 2011 | $519.26M | Feb 24, 2012 |
| FY2011 | Sep 30, 2011 | $509.62M | Feb 24, 2012 |
| FY2011 | Jun 30, 2011 | $489.35M | Feb 24, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | $1.18B | Feb 24, 2011 |
| FY2010 | Dec 31, 2009 | $1.10B | Feb 24, 2011 |
| FY2010 | Dec 31, 2008 | $1.12B | Feb 24, 2011 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.12B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.04B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $835.44M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $776.91M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $1.33B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $913.64M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $970.38M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $657.54M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $603.45M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $4.29B | Feb 21, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.16B | Feb 15, 2024 |
| FY2023 | Dec 31, 2022 | $1.12B | Feb 15, 2024 |
| FY2023 | Dec 31, 2021 | $1.68B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $1.32B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $1.36B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $1.11B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $1.00B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $856.09M | Feb 21, 2019 |
| FY2017 | Dec 31, 2015 | $1.01B | Feb 22, 2018 |
| FY2016 | Dec 31, 2014 | $921.64M | Feb 23, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.65B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.57B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.53B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.45B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $1.26B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $1.27B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $1.46B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $1.36B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $1.27B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.21B | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.75B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $20.83B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $20.03B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $20.22B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $21.17B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $20.29B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $21.17B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $20.39B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $20.57B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $20.70B | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.34B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $9.25B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $8.46B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $8.52B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $9.48B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $9.18B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $10.16B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $9.62B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $9.73B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $9.80B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.04B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $11.04B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $11.09B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $11.17B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $10.95B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $10.53B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $10.32B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $10.17B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $10.24B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $10.23B | Feb 22, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.19B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.41B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $1.44B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.66B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.83B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $1.40B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $1.39B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $1.26B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $1.40B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $1.54B | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.90M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $62.30M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $50.74M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $53.87M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $123.83M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $42.59M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $45.75M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $47.44M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $50.65M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $77.21M | Feb 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.24B | Feb 13, 2026 |
| FY2024 | Dec 31, 2024 | $8.19B | Feb 13, 2025 |
| FY2023 | Dec 31, 2023 | $7.46B | Feb 15, 2024 |
| FY2022 | Dec 31, 2022 | $7.49B | Feb 16, 2023 |
| FY2021 | Dec 31, 2021 | $8.42B | Feb 17, 2022 |
| FY2020 | Dec 31, 2020 | $8.13B | Feb 18, 2021 |
| FY2019 | Dec 31, 2019 | $9.13B | Feb 20, 2020 |
| FY2018 | Dec 31, 2018 | $8.91B | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | $9.07B | Feb 22, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | 11 | Feb 21, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | 11 | Feb 21, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 377.81M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 379.48M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 379.29M | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | 378.43M | Feb 13, 2026 |
| FY2024 | Dec 31, 2021 | 375.53M | Feb 13, 2025 |
| FY2023 | Dec 31, 2020 | 372.30M | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | 371.67M | Feb 16, 2023 |
| FY2021 | Dec 31, 2018 | 369.41M | Feb 17, 2022 |
| FY2020 | Dec 31, 2017 | 368.02M | Feb 18, 2021 |
| FY2019 | Dec 31, 2016 | 365.87M | Feb 20, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.05B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.02B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $990.15M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $931.78M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $900.47M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $883.94M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $831.11M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $782.12M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $739.38M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $4.77B | Feb 21, 2019 |